NewGen gets $19M valuation for planned UAE cytometry business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Outlook Therapeutics (OTLK) halted, news pending
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million
July 6, 2026 9:00 AM EDTMidpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot
Senior Strategic Advisor Nadeem Malik, former CEO of Genetics and IVF Institute and President of Fairfax Cryobank, to spearhead commercialization
BANGKOK, July 06, 2026 (GLOBE NEWSWIRE) -- NewGen Group Limited (Nasdaq: NIVF) (NewGen or the Company), a technology-driven, diversified growth company, today announced a compelling independent valuation from a Big Four global accounting firm for its planned UAE-based cell sorting and cytometry leasing business. The Report assigns a midpoint equity value of... More
